DekaBank Deutsche Girozentrale
MRNA icon

DekaBank Deutsche Girozentrale’s Moderna MRNA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Hold
220,245
– – 0.02% 432
2026
Q1 		$10.8M Hold
220,245
– – 0.02% 433
2025
Q4 		$26.9M Hold
220,245
– – 0.05% 283
2025
Q3 		$5.44M Hold
220,245
– – 0.01% 562
2025
Q2 		$6.05M Sell
220,245
-1,473
-0.7% -$38.8K 0.01% 535
2025
Q1 		$6.06M Buy
221,718
+1,473
+0.7% +$52.3K 0.01% 532
2024
Q4 		$8.76M Hold
220,245
– – 0.02% 477
2024
Q3 		$14.6M Sell
220,245
-968
-0.4% -$88.9K 0.03% 381
2024
Q2 		$27M Sell
221,213
-505
-0.2% -$63.9K 0.05% 270
2024
Q1 		$24.7M Buy
221,718
+27,705
+14% +$2.79M 0.05% 292
2023
Q4 		$19.2M Sell
194,013
-56,597
-23% -$4.76M 0.04% 320
2023
Q3 		$25.3M Buy
250,610
+10,459
+4% +$1.17M 0.06% 273
2023
Q2 		$29.3M Sell
240,151
-16,671
-6% -$2.22M 0.07% 258
2023
Q1 		$38.1M Buy
256,822
+7,405
+3% +$1.22M 0.1% 218
2022
Q4 		$44.2M Buy
249,417
+19,407
+8% +$3.17M 0.12% 203
2022
Q3 		$27.4M Sell
230,010
-96
-0% -$14.6K 0.08% 229
2022
Q2 		$32.8M Sell
230,106
-3,489
-1% -$499K 0.1% 209
2022
Q1 		$41M Buy
233,595
+46,909
+25% +$7.9M 0.1% 203
2021
Q4 		$46.4M Buy
186,686
+5,649
+3% +$1.65M 0.11% 185
2021
Q3 		$69.1M Sell
181,037
-71,832
-28% -$26.5M 0.19% 133
2021
Q2 		$60.3M Sell
252,869
-22,290
-8% -$3.98M 0.18% 143
2021
Q1 		$33M Buy
275,159
+47,659
+21% +$6.91M 0.11% 191
2020
Q4 		$26.9M Sell
227,500
-8,083
-3% -$818K 0.1% 202
2020
Q3 		$17.4M Buy
235,583
+170,959
+265% +$11.9M 0.08% 221
2020
Q2 		$4.01M Sell
64,624
-18,376
-22% -$1.01M 0.03% 350
2020
Q1 		$2.51M Buy
+83,000
New +$1.91M 0.02% 391

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MRNA Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Moderna (MRNA) position steady in Q2 2026 at 220,245 shares worth $10.6M. The position accounts for 0.02% of the portfolio, ranked #432.

DekaBank Deutsche Girozentrale first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $69.1M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 220,245 shares of Moderna worth $10.6M as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.02% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #432 holding.
  • DekaBank Deutsche Girozentrale first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • DekaBank Deutsche Girozentrale's Moderna position peaked at $69.1M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.